Overview

Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy

Status:
Unknown status

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess whether the addition of a drug such as Magnesium sulphate while providing therapeutic hypothermia (or cooling) to babies who are asphyxiated at birth provides additional benefit to the babies' survival and outcome compared to cooling alone.

Phase:

Phase 3

Details

Lead Sponsor:

Sajjad Rahman

Treatments:

Magnesium Sulfate